Claus-Jügen Maier

Title: Innovations of Claus-Jügen Maier in Pharmaceutical Chemistry

Introduction

Claus-Jügen Maier is a notable inventor based in Weinheim, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target the central nervous system. His work has implications for the treatment of various neurological disorders.

Latest Patents

Maier holds a patent for a method for the production of diarylcycloalkyl derivatives. This invention relates to a process for preparing diarylcycloalkyl derivatives of a specific formula. These compounds serve as activators for peroxisome proliferator-activated receptors (PPAR), which are beneficial in treating diseases such as multiple sclerosis and Parkinson's Disease. The novel process he developed allows for the preparation of these PPAR activators with high enantioselectivity, eliminating the need for subsequent chiral chromatography.

Career Highlights

Claus-Jügen Maier is associated with Sanofi-Aventis Deutschland GmbH, where he continues to innovate in the pharmaceutical sector. His expertise in chemical processes has positioned him as a valuable asset in the development of new therapeutic agents.

Collaborations

Maier has collaborated with notable colleagues, including Christophe Salagnac and Frank Zocher. These partnerships have enhanced the research and development efforts within his field.

Conclusion

Claus-Jügen Maier's contributions to pharmaceutical chemistry, particularly through his patented methods, demonstrate his commitment to advancing medical science. His work has the potential to improve treatment options for various neurological conditions.